Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events.
All articles by Haymarket Media
Removal Plus Transplant Surgery Feasible in Polycystic Kidney Disease
Simultaneous bilateral laparoscopic nephrectomy can be done at the time of living donor kidney transplant
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes.
Certain Hypertension Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia.
Sexual Activity Tied to Long-Term Survival After Heart Attack
Maintaining sexual activity in first 6 months after heart attack linked to one-third lower death risk.
More Than Half of Cancer Patients Willing to Enroll in Clinical Trials
Participation rates similar for Black and White patients, treatment and cancer control trials.
Individuals With Blood Group O Have Lower Risk for COVID-19
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT.
White House Approves Tougher Rules for COVID-19 Vaccine Development
Guidelines recommend participants in late-stage trials be followed for a median of at least 2 months.
BMD Testing Rates Low in Men Initiating ADT for Prostate Cancer
Odds of BMD testing up with history of osteoporosis, rheumatoid arthritis, bisphosphonate use.
COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways.
-
Loading...
-
Loading...
Next post in Urology
